Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

• Status: Completed
• Trial end date: 2010-04-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety, efficacy, and acceptability of two artificial tears compared to a currently available artificial tear in subjects with dry eye.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Glycerol; Lubricant Eye Drops

Criteria

Inclusion Criteria:

• Current use of an artificial tear at least twice daily, for at least three months prior to Day 1, on average

• Ability/agreement to wear habitual correction (glasses) during study period

Exclusion Criteria:

• Known allergy or sensitivity to the study product(s) or its components

• Anticipate contact lens wear during the study, or subject has worn contact lenses in the last six months

• Chronic use of systemic medications which may affect a dry eye condition

• Active ocular allergy or infection

• Use of Restasis® or other topical cyclosporine products within 3 months prior to Day 1

• Current use of any topical ophthalmic medications, have used within 2 weeks prior to Day 1, or are likely to use during study.